Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Helander

Showing results (41-50 of 160) with videos related to

Pageof 16
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|April 18, 2015
Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidineAnders Helander, Olof Beck, Matilda Bäckberg
Lakartidningen|October 27, 2020
[Harmonized measurement and reporting of chiral amphetamine in the follow-up of ADHD treatment]Anders Helander, Tomas Villen, Elin Widing
Alcoholism, Clinical and Experimental Research|August 10, 2002
Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and DependenceAnders Helander, C J Peter Eriksson,
Plos One|April 24, 2020
Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA projectAnders Helander, Matilda Bäckberg, Olof Beck
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 19, 2007
Evaluation of a new immunoassay for urinary ethyl glucuronide testingMichael Böttcher, Olof Beck, Anders Helander
Clinical Toxicology (Philadelphia, Pa.)|November 29, 2018
An analytically confirmed non-fatal intoxication by carfentanil in SwedenLisa Franzén, Olof Beck, Anders Helander
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 14, 2012
Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment settingAnders Helander, Oszkár Péter, Yufang Zheng
Drug Testing and Analysis|April 11, 2024
Alternative routine for reporting chiral amphetamine test results in assessment of attention-deficit/hyperactivity disorder medication: experiences from 2013 to 2023Anders Helander, Annika Andersson, Tomas Villén
Journal of Analytical Toxicology|April 10, 2008
Development and clinical application of an LC-MS-MS method for mescaline in urineKristian Björnstad, Anders Helander, Olof Beck
Clinical Chemistry and Laboratory Medicine|December 19, 2016
Identification and quantitation of phosphatidylethanols in oral fluid by liquid chromatography-tandem mass spectrometryShahid Ullah, Anders Helander, Olof Beck
Pageof 16

Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
Clinical Toxicology (Philadelphia, Pa.)|April 18, 2015
Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidineAnders Helander, Olof Beck, Matilda Bäckberg
Lakartidningen|October 27, 2020
[Harmonized measurement and reporting of chiral amphetamine in the follow-up of ADHD treatment]Anders Helander, Tomas Villen, Elin Widing
Alcoholism, Clinical and Experimental Research|August 10, 2002
Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and DependenceAnders Helander, C J Peter Eriksson,
Plos One|April 24, 2020
Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA projectAnders Helander, Matilda Bäckberg, Olof Beck
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 19, 2007
Evaluation of a new immunoassay for urinary ethyl glucuronide testingMichael Böttcher, Olof Beck, Anders Helander
Clinical Toxicology (Philadelphia, Pa.)|November 29, 2018
An analytically confirmed non-fatal intoxication by carfentanil in SwedenLisa Franzén, Olof Beck, Anders Helander
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 14, 2012
Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment settingAnders Helander, Oszkár Péter, Yufang Zheng
Drug Testing and Analysis|April 11, 2024
Alternative routine for reporting chiral amphetamine test results in assessment of attention-deficit/hyperactivity disorder medication: experiences from 2013 to 2023Anders Helander, Annika Andersson, Tomas Villén
Journal of Analytical Toxicology|April 10, 2008
Development and clinical application of an LC-MS-MS method for mescaline in urineKristian Björnstad, Anders Helander, Olof Beck
Clinical Chemistry and Laboratory Medicine|December 19, 2016
Identification and quantitation of phosphatidylethanols in oral fluid by liquid chromatography-tandem mass spectrometryShahid Ullah, Anders Helander, Olof Beck
Pageof 16